Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

277 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Elements of cancer immunity and the cancer-immune set point.
Chen DS, Mellman I. Chen DS, et al. Among authors: mellman i. Nature. 2017 Jan 18;541(7637):321-330. doi: 10.1038/nature21349. Nature. 2017. PMID: 28102259 Review.
Private lives: reflections and challenges in understanding the cell biology of the immune system.
Mellman I. Mellman I. Science. 2007 Aug 3;317(5838):625-7. doi: 10.1126/science.1142955. Science. 2007. PMID: 17673653
Coordinated protein sorting, targeting and distribution in polarized cells.
Mellman I, Nelson WJ. Mellman I, et al. Nat Rev Mol Cell Biol. 2008 Nov;9(11):833-45. doi: 10.1038/nrm2525. Nat Rev Mol Cell Biol. 2008. PMID: 18946473 Free PMC article. Review.
Spatial control of EGF receptor activation by reversible dimerization on living cells.
Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I. Chung I, et al. Among authors: mellman i. Nature. 2010 Apr 1;464(7289):783-7. doi: 10.1038/nature08827. Epub 2010 Mar 7. Nature. 2010. PMID: 20208517
Epidermal growth factor receptor (EGFR) is a type I receptor tyrosine kinase, the deregulation of which has been implicated in a variety of human carcinomas. ...
Epidermal growth factor receptor (EGFR) is a type I receptor tyrosine kinase, the deregulation of which has been implicated in a vari …
Immunology. Beta-catenin balances immunity.
Mellman I, Clausen BE. Mellman I, et al. Science. 2010 Aug 13;329(5993):767-9. doi: 10.1126/science.1194185. Science. 2010. PMID: 20705838 No abstract available.
Harnessing dendritic cells for immunotherapy.
Delamarre L, Mellman I. Delamarre L, et al. Among authors: mellman i. Semin Immunol. 2011 Feb;23(1):2-11. doi: 10.1016/j.smim.2011.02.001. Epub 2011 Mar 5. Semin Immunol. 2011. PMID: 21377379 Review.
Cancer immunotherapy comes of age.
Mellman I, Coukos G, Dranoff G. Mellman I, et al. Nature. 2011 Dec 21;480(7378):480-9. doi: 10.1038/nature10673. Nature. 2011. PMID: 22193102 Free PMC article. Review.
Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.
Smed-Sörensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, Nakamura N, Delamarre L, Mellman I. Smed-Sörensen A, et al. Among authors: mellman i. PLoS Pathog. 2012;8(3):e1002572. doi: 10.1371/journal.ppat.1002572. Epub 2012 Mar 8. PLoS Pathog. 2012. PMID: 22412374 Free PMC article.
Although infected mDCs efficiently presented endogenous IAV antigens on MHC class II, this was not the case for presentation on MHC class I. ...Furthermore, IAV infection also impaired cross-presentation of other exogenous antigens, indicating that IAV infection broadly at …
Although infected mDCs efficiently presented endogenous IAV antigens on MHC class II, this was not the case for presentation on MHC class …
Oncology meets immunology: the cancer-immunity cycle.
Chen DS, Mellman I. Chen DS, et al. Among authors: mellman i. Immunity. 2013 Jul 25;39(1):1-10. doi: 10.1016/j.immuni.2013.07.012. Immunity. 2013. PMID: 23890059 Review.
Antibody therapeutics in cancer.
Sliwkowski MX, Mellman I. Sliwkowski MX, et al. Among authors: mellman i. Science. 2013 Sep 13;341(6151):1192-8. doi: 10.1126/science.1241145. Science. 2013. PMID: 24031011 Review.
277 results
Jump to page
Feedback